228 related articles for article (PubMed ID: 19473900)
1. [Hyperprolactinemia in a child diagnosed with Asperger syndrome and hyperkinetic disorder treated with risperidone].
Monge Galindo L; Escosa García L; García Sánchez N; Ruiz-Lázaro PM
An Pediatr (Barc); 2009 Jul; 71(1):86-7. PubMed ID: 19473900
[No Abstract] [Full Text] [Related]
2. Risperidone-induced sexual dysfunction in a prepubertal child - a case report.
Wadoo O; Chalhoub N
J Psychopharmacol; 2009 Aug; 23(6):727-8. PubMed ID: 18562402
[TBL] [Abstract][Full Text] [Related]
3. Risperidone and withdrawal dyskinesia.
Lore C
J Am Acad Child Adolesc Psychiatry; 2000 Aug; 39(8):941. PubMed ID: 10939219
[No Abstract] [Full Text] [Related]
4. Case report: valproic Acid and risperidone treatment leading to development of hyperammonemia and mania.
Carlson T; Reynolds CA; Caplan R
J Am Acad Child Adolesc Psychiatry; 2007 Mar; 46(3):356-361. PubMed ID: 17314721
[TBL] [Abstract][Full Text] [Related]
5. Risperidone and tardive dyskinesia.
Feeney DJ; Klykylo W
J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1421-2. PubMed ID: 8936904
[No Abstract] [Full Text] [Related]
6. Efficacy of risperidone treatment in Smith-Magenis syndrome (del 17 pll. 2).
Niederhofer H
Psychiatr Danub; 2007 Sep; 19(3):189-92. PubMed ID: 17914318
[TBL] [Abstract][Full Text] [Related]
7. A washout period needed before switching from a neuroleptic to an amphetamine.
Prescrire Int; 2009 Aug; 18(102):165. PubMed ID: 19743579
[TBL] [Abstract][Full Text] [Related]
8. [Galactorrhea and secondary amenorrhea in hyperprolactinemia].
Wallmeroth A; Staub JJ
Praxis (Bern 1994); 2000 Aug; 89(34):1341-3. PubMed ID: 11021189
[No Abstract] [Full Text] [Related]
9. The combined pharmacotherapy controversy.
Wakefield TP
J Am Acad Child Adolesc Psychiatry; 1996 Jan; 35(1):1-2. PubMed ID: 8567600
[No Abstract] [Full Text] [Related]
10. Hyperprolactinemia in an adolescent with psychotic disorder on risperidone.
Jummani R; Coffey BJ
J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):791-4. PubMed ID: 20035598
[No Abstract] [Full Text] [Related]
11. TD from risperidone?
Edleman RJ
J Am Acad Child Adolesc Psychiatry; 1997 Jul; 36(7):867. PubMed ID: 9204659
[No Abstract] [Full Text] [Related]
12. [Impact of neuroleptic-induced hyperprolactinemia on sexual dysfunction in male schizophrenic patients].
Konarzewska B; Szulc A; Popławska R; Galińska B; Juchnowicz D
Psychiatr Pol; 2008; 42(1):87-95. PubMed ID: 18567406
[TBL] [Abstract][Full Text] [Related]
13. Granulomatous cutaneous lesions associated with risperidone-induced hyperprolactinemia in an amputated upper limb.
Lin CH; Ma H; Chung MT; Chou J
Int J Dermatol; 2012 Jan; 51(1):75-8. PubMed ID: 21834946
[No Abstract] [Full Text] [Related]
14. Risperidone in children with autism and serious behavioral problems.
Valiquette G
N Engl J Med; 2002 Dec; 347(23):1890-1; author reply 1890-1. PubMed ID: 12472071
[No Abstract] [Full Text] [Related]
15. Oxyprothepin and clorotepin compared in the hyperkinetic syndrome.
Výborová L; Náhunek K; Drtilková I; Balastíková B
Act Nerv Super (Praha); 1989 Apr; 31(1):45-6. PubMed ID: 2571227
[No Abstract] [Full Text] [Related]
16. [Hyperprolactinemia induced by neuroleptics].
Lakartidningen; 2007 May 9-15; 104(19):1522. PubMed ID: 17550031
[No Abstract] [Full Text] [Related]
17. Pharmacokinetics study for hyperprolactinemia among schizophrenics switched from risperidone to risperidone long-acting injection.
Bai YM; Chen TT; Lin WK; Chang WH; Wu B; Hung CH; Chou P; Chen JY
J Clin Psychopharmacol; 2007 Jun; 27(3):306-8. PubMed ID: 17502783
[No Abstract] [Full Text] [Related]
18. A case of antipsychotic-induced hyperglycemia in a child with insulin dependent diabetes mellitus.
Stern AP; Trieu ML
J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):403-4. PubMed ID: 23083030
[No Abstract] [Full Text] [Related]
19. Low-dose risperidone augmentation of antidepressants or anxiolytics is associated with hyperprolactinemia.
Kopecek M; Bares M; Horacek J; Mohr P
Neuro Endocrinol Lett; 2006 Dec; 27(6):803-6. PubMed ID: 17187006
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic drug-induced hyperprolactinemia: clinical implications.
Molitch ME
Endocr Pract; 2000; 6(6):479-81. PubMed ID: 11155224
[No Abstract] [Full Text] [Related]
[Next] [New Search]
